Elsevier

The Lancet

Volume 379, Issue 9835, 30 June–6 July 2012, Pages 2409-2411
The Lancet

Comment
Pre-exposure prophylaxis for HIV prevention: how to predict success

https://doi.org/10.1016/S0140-6736(11)61852-7Get rights and content

First page preview

First page preview
Click to open first page preview
View PDF

References (15)

  • MS Cohen et al.

    Prevention of HIV-1 infection with early antiretroviral therapy

    N Engl J Med

    (2011)
  • Q Abdool Karim et al.

    Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

    Science

    (2010)
  • RM Grant et al.

    Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

    N Engl J Med

    (2010)
  • M Thigpen et al.

    Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study. 6th IAS Conference; July 17–20, 2011. Rome, Italy. WELBC01 oral abstract

  • J Baeton et al.

    Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: The Partners PrEP Study. 6th IAS Conference; July 17–20, 2011. Rome, Italy. Abstract MOAX0106

  • FHI360

There are more references available in the full text version of this article.

Cited by (0)

View full text
Copyright © 2012 Elsevier Ltd. All rights reserved.